Solesence Inc(SLSN) - 2024 Q1 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to _______ to _______ Commission File Number: 000-22333 Nanophase Technologies Corporation (Exact name of registrant as specified in its charter) Delaware 36-3687863 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 1319 Marquette Drive, Romeoville, Illinois ...